Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Clinical trial NCT02460198 · COMPLETED
Trial details
- NCT number
- NCT02460198
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-25
- Primary completion
- 2019-09-09
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.